Abstract
This study aims to develop and validate a prognostic nomogram that accurately predicts the short-term survival rate of cirrhotic patients with acute kidney damage (AKI) upon ICU admission. For this purpose, we examined the admission data of 3060 cirrhosis patients with AKI from 2008 to 2019 in the MIMIC-IV database. All included patients were randomly assigned to derivation and validation cohorts in a 7:3 ratio. The derivation cohort used the least absolute shrinkage and selection operator (LASSO) regression model to identify independent predictors of AKI. A prognostic nomogram was constructed via multivariate logistic regression analysis in the derivation cohort and subsequently verified in the validation cohort. Nomogram's discrimination, calibration, and clinical utility were evaluated using the C-index, calibration plot, and decision curve analysis (DCA). A total of 2138 patients were enrolled in the derivation cohort, with a median follow-up period of 15 days, a median survival time of 41 days, and a death rate of 568 patients (26.6%). The cumulative survival rates at 15 and 30 days were 75.8% and 57.5%, respectively. The results of the multivariate analysis indicated that advanced AKI stage, use of vasoactive drugs, advanced age, lower levels of ALB, lower mean sBp, longer INR, and longer PT were all independent risk factors that significantly influenced the all-cause mortality of cirrhosis patients with AKI (all p < 0.01). The C-indices for the derivation and the validation cohorts were 0.821 (95% CI 0.800–0.842) and 0.831 (95% CI 0.810–0.852), respectively. The model’s calibration plot demonstrated high consistency between predicted and actual probabilities. Furthermore, the DCA showed that the nomogram was clinically valuable. Therefore, the developed and internally validated prognostic nomogram exhibited favorable discrimination, calibration, and clinical utility in forecasting the 15-day and 30-day survival rates of cirrhosis patients with AKI upon admission to the ICU.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
References
Mokdad AH, Forouzanfar MH, Daoud F, Mokdad AA, El Bcheraoui C, Moradi-Lakeh M, Kyu HH, Barber RM, Wagner J, Cercy K et al (2016) Global burden of diseases, injuries, and risk factors for young people’s health during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (Lond Engl) 387(10036):2383–2401
Williams R, Alexander G, Armstrong I, Baker A, Bhala N, Camps-Walsh G, Cramp ME, de Lusignan S, Day N, Dhawan A et al (2018) Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK. Lancet (Lond Engl) 391(10125):1097–1107
Asrani SK, Devarbhavi H, Eaton J, Kamath PS (2019) Burden of liver diseases in the world. J Hepatol 70(1):151–171
Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS (2021) Liver cirrhosis. Lancet (Lond Engl) 398(10308):1359–1376
Smith A, Baumgartner K, Bositis C (2019) Cirrhosis: diagnosis and management. Am Family Phys 100(12):759–770
Busk TM, Bendtsen F, Møller S (2016) Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects. Expert Rev Gastroenterol Hepatol 10(10):1153–1161
Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A, Moreau R, Jalan R, Sarin SK, Piano S et al (2015) Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut 64(4):531–537
Mindikoglu AL, Hernaez R, Liu Y, Kramer JR, Taylor T, Rana A, Kanwal F (2020) Renal trajectory patterns are associated with postdischarge mortality in patients with cirrhosis and acute kidney injury. Clin Gastroenterol Hepatol 18(8):1858-1866.e1856
Ginès P, Schrier RW (2009) Renal failure in cirrhosis. N Engl J Med 361(13):1279–1290
Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS et al (2015) International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet (Lond Engl) 385(9987):2616–2643
Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D et al (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41(8):1411–1423
Oliveros H, Buitrago G (2020) Effect of renal support therapy on 5-year survival in patients discharged from the intensive care unit. J Intensive Care 8:63
Bonavia A, Singbartl K (2018) Kidney injury and electrolyte abnormalities in liver failure. Semin Respir Crit Care Med 39(5):556–565
Nadim MK, Garcia-Tsao G (2023) Acute kidney injury in patients with cirrhosis. N Engl J Med 388(8):733–745
Cullaro G, Kanduri SR, Velez JCQ (2022) Acute kidney injury in patients with liver disease. Clin J Am Soc Nephrol CJASN 17(11):1674–1684
Cullaro G, Verna EC, Lai JC (2019) Association between renal function pattern and mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 17(11):2364–2370
Murugan R, Kellum JA (2011) Acute kidney injury: what’s the prognosis? Nat Rev Nephrol 7(4):209–217
Huang Y-q, Liang C-h (2016) He L, Tian J, Liang C-s, Chen X, Ma Z-l, Liu Z-y: Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34(18):2157–2164
Iasonos A, Schrag D, Raj GV, Panageas KS (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26(8):1364–1370
Johnson A, Bulgarelli, L., Pollard, T., Horng, S., Celi, L. A., & Mark, R. (2022). MIMIC-IV (version 2.0). PhysioNet. 10.13026/7vcr-e114.
Kellum JA, Lameire N (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care (Lond Engl) 17(1):204
Zhang Z (2016) Missing data imputation: focusing on single imputation. Ann Transl Med 4(1):9
Sauerbrei W, Royston P, Binder H (2007) Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med 26(30):5512–5528
Feng LH, Lu Y, Ren S, Liang H, Wei L, Jiang J (2023) Development and validation of a dynamic online nomogram for predicting acute kidney injury in cirrhotic patients upon ICU admission. Front Med 10:1055137
Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ, McGinn T, Guyatt G (2017) Discrimination and calibration of clinical prediction models: users’ guides to the medical literature. JAMA 318(14):1377–1384
Cullaro G, Rubin JB, Fortune BE, Crawford CV, Verna EC, Hsu CY, Liu KD, Brown RS, Lai JC, Rosenblatt R (2022) Association between kidney dysfunction types and mortality among hospitalized patients with cirrhosis. Digest Dis Sci 67(7):3426–3435
Rajakumar A, Appuswamy E, Kaliamoorthy I, Rela M (2021) Renal dysfunction in cirrhosis: critical care management. Indian J Crit Care Med 25(2):207–214
Khemichian S, Francoz C, Nadim MK (2021) Advances in management of hepatorenal syndrome. Curr Opin Nephrol Hypertens 30(5):501–506
Nadim MK, Durand F, Kellum JA, Levitsky J, O’Leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P et al (2016) Management of the critically ill patient with cirrhosis: a multidisciplinary perspective. J Hepatol 64(3):717–735
Flamm SL, Wong F, Ahn J, Kamath PS (2022) AGA clinical practice update on the evaluation and management of acute kidney injury in patients with cirrhosis: expert review. Clin Gastroenterol Hepatol 20(12):2707–2716
Davenport A (2010) Management of acute kidney injury in liver disease. Contribut Nephrol 165:197–205
Thévenot T, Bureau C, Oberti F, Anty R, Louvet A, Plessier A, Rudler M, Heurgué-Berlot A, Rosa I, Talbodec N et al (2015) Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial. J Hepatol 62(4):822–830
Localio AR, Goodman S (2012) Beyond the usual prediction accuracy metrics: reporting results for clinical decision making. Ann Intern Med 157(4):294–295
Van Calster B, Vickers AJ (2015) Calibration of risk prediction models: impact on decision-analytic performance. Med Decis Making 35(2):162–169
Collins GS, Reitsma JB, Altman DG, Moons KG (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ (Clin Res ed) 350:g7594
Acknowledgements
Not applicable.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors have any conflicts of interest to declare.
Ethical approval and consent to participate
The establishment of MIMIC-IV (v2.0) was approved by the institutional review boards of the Beth Israel Deaconess Medical Center (Boston, MA) and Massachusetts Institute of Technology (Cambridge, MA). Thus, this study was granted a waiver of informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liao, T., Lu, Y., Su, T. et al. Development and validation of prognostic nomogram for cirrhotic patients with acute kidney injury upon ICU admission. Intern Emerg Med 19, 49–58 (2024). https://doi.org/10.1007/s11739-023-03436-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-023-03436-z